tm logo
XENPOZYME
Live/Registered
REGISTERED

on 17 Jan 2023

Last Applicant/ Owned by

450 Water Street

Cambridge

MA

02141

Serial Number

88330513 filed on 07th Mar 2019

Registration Number

6957890 registered on 17th Jan 2023

in the Principal Register

Correspondent Address

Karen Lim

FROSS ZELNICK LEHRMAN & ZISSU, P.C.

151 WEST 42nd St., 17 Fl.

NEW YORK, NY 10036

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XENPOZYME

Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections


First Use Date in General

16th Sep 2022

First Use Date in Commerce

16th Sep 2022

Specimens


XENPOZYME specimen

Mark Details


Serial Number

No 88330513

Mark Type

No Service/Collective Mark

Attorney Docket Number

No GENZ 1903732

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Jan 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Jan 2023REGISTERED-PRINCIPAL REGISTER
14th Dec 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
13th Dec 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
28th Sep 2022STATEMENT OF USE PROCESSING COMPLETE
23rd Sep 2022USE AMENDMENT FILED
23rd Sep 2022TEAS STATEMENT OF USE RECEIVED
09th Apr 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08th Apr 2022SOU EXTENSION 5 GRANTED
08th Apr 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL